| Zachary Alexis Adams, MD | |
|
1665 Dominican Way Ste 222, Santa Cruz, CA 95065-1515 | |
| (844) 387-5337 | |
| (866) 264-3890 |
| Full Name | Zachary Alexis Adams |
|---|---|
| Gender | Male |
| Speciality | Sleep Medicine |
| Experience | 11 Years |
| Location | 1665 Dominican Way Ste 222, Santa Cruz, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073956231 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QS1201X | Family Medicine - Sleep Medicine | A167567 (California) | Primary |
| 207QS1201X | Family Medicine - Sleep Medicine | 60894787 (Washington) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aaron B Morse Md Inc | 3072597848 | 4 |
| Sirish Nakka Md Inc | 6608224423 | 4 |
News Archive
According to US researchers, data on drugs that could save money and help doctors make smarter treatment decisions are often unavailable at the time new medicines hit the market. They released a study this Tuesday in Journal of the American Medical Association which found nearly a third of new drug approvals from the Food and Drug Administration included no data on how well the medications compare with existing alternatives.
Brown University researchers have developed a simple method for isolating placental cells from cervical swabs. The technique, described in the journal Scientific Reports, could aid in developing less invasive ways of diagnosing genetic disorders in developing fetuses.
Bristol-Myers Squibb Company today announced the awarding of a Positive Charge grant to the American College of Physicians Foundation to support ACP Foundation's HIV workforce capacity building initiative.
The Wall Street Journal reported that the Obama administration acknowledged Sunday that it needs to make design, as well as capacity, fixes to the website set up to help consumers shop for health coverage. Other news outlets examined the capacity challenges faced both by the federal and state exchanges and the adjustments made over the weekend.
Zogenix, Inc., a privately held pharmaceutical company, announced that it has initiated a pivotal Phase 3 clinical trial with ZX002, a novel, oral, controlled-release formulation of hydrocodone without acetaminophen. ZX002 is being developed for the treatment of moderate to severe pain in individuals who require around-the-clock opioid therapy for the control of pain.
› Verified 2 days ago
| Entity Name | Aaron B Morse Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053585794 PECOS PAC ID: 3072597848 Enrollment ID: O20040617001092 |
News Archive
According to US researchers, data on drugs that could save money and help doctors make smarter treatment decisions are often unavailable at the time new medicines hit the market. They released a study this Tuesday in Journal of the American Medical Association which found nearly a third of new drug approvals from the Food and Drug Administration included no data on how well the medications compare with existing alternatives.
Brown University researchers have developed a simple method for isolating placental cells from cervical swabs. The technique, described in the journal Scientific Reports, could aid in developing less invasive ways of diagnosing genetic disorders in developing fetuses.
Bristol-Myers Squibb Company today announced the awarding of a Positive Charge grant to the American College of Physicians Foundation to support ACP Foundation's HIV workforce capacity building initiative.
The Wall Street Journal reported that the Obama administration acknowledged Sunday that it needs to make design, as well as capacity, fixes to the website set up to help consumers shop for health coverage. Other news outlets examined the capacity challenges faced both by the federal and state exchanges and the adjustments made over the weekend.
Zogenix, Inc., a privately held pharmaceutical company, announced that it has initiated a pivotal Phase 3 clinical trial with ZX002, a novel, oral, controlled-release formulation of hydrocodone without acetaminophen. ZX002 is being developed for the treatment of moderate to severe pain in individuals who require around-the-clock opioid therapy for the control of pain.
› Verified 2 days ago
| Entity Name | Sirish Nakka Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609579069 PECOS PAC ID: 6608224423 Enrollment ID: O20231204002899 |
News Archive
According to US researchers, data on drugs that could save money and help doctors make smarter treatment decisions are often unavailable at the time new medicines hit the market. They released a study this Tuesday in Journal of the American Medical Association which found nearly a third of new drug approvals from the Food and Drug Administration included no data on how well the medications compare with existing alternatives.
Brown University researchers have developed a simple method for isolating placental cells from cervical swabs. The technique, described in the journal Scientific Reports, could aid in developing less invasive ways of diagnosing genetic disorders in developing fetuses.
Bristol-Myers Squibb Company today announced the awarding of a Positive Charge grant to the American College of Physicians Foundation to support ACP Foundation's HIV workforce capacity building initiative.
The Wall Street Journal reported that the Obama administration acknowledged Sunday that it needs to make design, as well as capacity, fixes to the website set up to help consumers shop for health coverage. Other news outlets examined the capacity challenges faced both by the federal and state exchanges and the adjustments made over the weekend.
Zogenix, Inc., a privately held pharmaceutical company, announced that it has initiated a pivotal Phase 3 clinical trial with ZX002, a novel, oral, controlled-release formulation of hydrocodone without acetaminophen. ZX002 is being developed for the treatment of moderate to severe pain in individuals who require around-the-clock opioid therapy for the control of pain.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Zachary Alexis Adams, MD 1665 Dominican Way Ste 222, Santa Cruz, CA 95065-1515 Ph: (844) 387-5337 | Zachary Alexis Adams, MD 1665 Dominican Way Ste 222, Santa Cruz, CA 95065-1515 Ph: (844) 387-5337 |
News Archive
According to US researchers, data on drugs that could save money and help doctors make smarter treatment decisions are often unavailable at the time new medicines hit the market. They released a study this Tuesday in Journal of the American Medical Association which found nearly a third of new drug approvals from the Food and Drug Administration included no data on how well the medications compare with existing alternatives.
Brown University researchers have developed a simple method for isolating placental cells from cervical swabs. The technique, described in the journal Scientific Reports, could aid in developing less invasive ways of diagnosing genetic disorders in developing fetuses.
Bristol-Myers Squibb Company today announced the awarding of a Positive Charge grant to the American College of Physicians Foundation to support ACP Foundation's HIV workforce capacity building initiative.
The Wall Street Journal reported that the Obama administration acknowledged Sunday that it needs to make design, as well as capacity, fixes to the website set up to help consumers shop for health coverage. Other news outlets examined the capacity challenges faced both by the federal and state exchanges and the adjustments made over the weekend.
Zogenix, Inc., a privately held pharmaceutical company, announced that it has initiated a pivotal Phase 3 clinical trial with ZX002, a novel, oral, controlled-release formulation of hydrocodone without acetaminophen. ZX002 is being developed for the treatment of moderate to severe pain in individuals who require around-the-clock opioid therapy for the control of pain.
› Verified 2 days ago
Carrie Coxwell Eisberg, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 250 Locust St, Santa Cruz, CA 95060 Phone: 831-427-3500 | |
Wendy Sickels, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Locust St, Santa Cruz, CA 95060 Phone: 831-427-3500 | |
Dr. Stephen Michael Stein, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 303 Potrero St, Ste 05a, Santa Cruz, CA 95060 Phone: 831-425-1385 Fax: 831-425-1385 | |
Dr. Steven Alberto Cortes, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 550 Water St, Suite A, Santa Cruz, CA 95060 Phone: 831-425-0420 Fax: 831-425-0185 | |
Dr. Andrew Luckett, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 21507 E Cliff Dr, Santa Cruz, CA 95062 Phone: 831-427-3500 | |
Mrs. Tasha L Turzo, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 550 Water St, K 4, Santa Cruz, CA 95060 Phone: 831-423-2298 Fax: 831-460-0204 | |
Dr. Diana Maria Mokaya, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1080 Emeline Ave, Santa Cruz, CA 95060 Phone: 831-454-4491 |